Companies /Healthcare

Elevance Health Inc

NYSE: ELV Healthcare Plans
$433.98
▼ $12.31 (−2.76%) today
Markets closed · 5:31pm ET

24/7 Wall St. View

ELV at a Glance

Valuation
Market cap
$92.8B
P/E ratio
18.3
Dividend yield
1.60%
Profitability
Revenue (TTM)
$201.8B
Profit margin
2.6%
EPS (TTM)
$23.55
Price
52-week range
$271 – $451
24/7 target
$654.78
Street target
$482.38
Earnings
Next report
Jan 26, 2027

Headquartered in Indianapolis, IN Fiscal year ends December NYSE: ELV elevancehealth.com

About Elevance Health

Elevance Health, Inc. (NYSE: ELV) is a diversified health services company that serves approximately 104 million consumers through a portfolio of medical, pharmacy, behavioral, clinical, home health, and complex care solutions. The company operates through four reportable segments: Health Benefits (encompassing Individual/ACA, Employer Group risk-based and fee-based, BlueCard, Medicare, Medicaid, and Federal Employee Program businesses), CarelonRx (pharmacy services including specialty pharmacy), Carelon Services (healthcare services and risk-based care solutions), and Corporate & Other. As of June 30, 2026, Elevance Health had approximately 44.9 million medical members. The company is a Blue Cross Blue Shield licensee and is focused on medical cost management, member experience, provider connectivity, operating efficiency, and value-based care through its Carelon platform. Updated

Latest Activity

ELVElevance Health
52-week high
$446.42
+0.26%vs prior 52-week high · Oct 22, 2026

Elevance Health closed at a fresh one-year high of $446.42, 0.26% above its prior peak set on October 22. Competitor Clover Health slipped 0.2% on the day.

Related stockstoday

Moves: Nov 16, 2026 · Alpha Vantage daily close

2 have no US listing

Biggest movers · At the close
  • BILLBill Holdings$57.31+5.2%
  • ELVElevance Health$446.11+3.8%
  • HUMHumana$462.49+2.7%
  • DUOLDuolingo$169.56+2.6%
  • HCAHCA Healthcare$511.55+2.5%
  • IQiQIYI$0.69-17.3%
  • NVTSNavitas Semiconductor$7.9-11.8%
  • IRENIREN$16.35-10.0%
  • AAOIApplied Optoelectronics$44.95-9.9%
  • TEMTempus AI$64.65-9.7%

Sellers controlled the close, with iQIYI down 17.27% on the day it filed third quarter results and no gainer topping a fraction of that. Healthcare took the top three slots after Bill Holdings.

Biggest movers · On the open
  • ELVElevance Health$443.16+3.1%
  • HCAHCA Healthcare$512.29+2.7%
  • SBUXStarbucks$109.09+2.5%
  • ARGXargenx$980.72+2.1%
  • GILDGilead Sciences$171.55+2.1%
  • IQiQIYI$0.71-14.7%
  • ASXASE Technology Holding$32.44-8.7%
  • SNDKSanDisk$808.84-8.6%
  • COHRCoherent$199.62-8.5%
  • LITELumentum$545.81-8.5%

Healthcare is leading at the open while AI hardware lags: SanDisk, Coherent, Lumentum and ASE Technology are all down roughly 8.5% or more, with Elevance, HCA and Gilead on the upside. iQIYI drops 14.7% after filing its third-quarter earnings report this morning.

CLOVClover Health
After-hours
$4.82
+9.05%off the open $4.42

The 9.05% run came the same day Humana, a competitor, posted Q3 2026 results. Managed care names moved together into the close.

Before the movelast 24 hours
  1. Earnings release
    Related company: HUM, competitor

    Humana Q3 2026 earnings release

Related stockstoday

Moves: Nov 6, 4:20 PM ET · Alpha Vantage quote

3 more related stocks · 4 have no US listing

Sold Elevance Health, Inc.$1M2,343 shares @ $441.34

Elevance's CFO cut roughly a third of his reported common stock in one day, selling 10,584 shares for about $4.65 million into prices as high as $447.19. No 10b5-1 plan is flagged, which makes this a discretionary exit by the person who knows the Medicare Advantage cost math best.

ELVElevance Health
Regular session
$426.70
-4.38%open $446.25

The managed-care insurer heads into today's earnings report already on the back foot, down 4.38% on the day. That slide sets a low bar for how the report lands.

ELVElevance Health, Inc.
Reports Wed Oct 21Before openConfirmed

Elevance reports before the open at 6:00 AM ET with four straight EPS beats behind it, the last one topping estimates by 20.6%. Consensus sits at $4.69 on $49.16 billion in revenue, and Medicare Advantage cost trends are the line that decides how insurers trade today.

    ELVElevance Health
    New 52-week high$425.27+0.1% vs prior high · 2026-07-14

    Elevance Health just set a new 52-week high at $425.27, a full round trip from its March low.

    ELV Coverage

    Frequently Asked Questions

    What does Elevance Health do?

    Elevance Health, Inc. (NYSE: ELV) is a diversified health services company that serves approximately 104 million consumers through a portfolio of medical, pharmacy, behavioral, clinical, home health, and complex care solutions.

    What is the ELV stock price target?

    24/7 Wall St.'s 12-month price target for ELV is $654.78, rated Buy. The Wall Street consensus target is $482.38. ELV price prediction →